Results 31 to 40 of about 29,772 (222)
Cutaneous and Mucocutaneous Leishmaniasis
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also
I, Abadías-Granado +4 more
openaire +3 more sources
Age-related alteration of arginase activity impacts on severity of leishmaniasis. [PDF]
BACKGROUND: The leishmaniases are a group of vector-borne parasitic diseases that represent a major international public health problem; they belong to the most neglected tropical diseases and have one of the highest rates of morbidity and mortality. The
Asrat Hailu +40 more
core +1 more source
Cutaneous Bronchogenic Cyst in a 3-Year-Old Girl: A Case Report
مقدمه: کیستهای برونکوژنیک در نتیجهی رشد ایزولهی درخت برونشیال و به طور معمول در مدیاستین ایجاد میشوند، اما ممکن است به طور نادر به صورت سابکوتانه و یا پوستی تظاهر کنند. این مطالعه، به گزارش یک مورد از این بیماری در یک دختر 3 ساله میپردازد.
Zahra Tafazzoli +5 more
doaj +1 more source
Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. [PDF]
BACKGROUND: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. Since 1998 HealthNet
Reithinger, Richard +5 more
core +1 more source
Background: Cutaneous leishmaniasis is an infectious disease caused by the protozoa of Leishmania genus, which cause serious public health issues in endemic regions across 80 countries.
Reza Mortezaei +3 more
doaj +1 more source
Therapy of cutaneous leishmaniasis
There have been many treatment modalities used for the therapy of cutaneous leishmaniasis. Although treatment need not be given for cosmetically insignificant lesions, which are often self-limited, therapy is usually indicated for larger, cosmetically significant and disfiguring lesions, and lesions which progress.
Lee, Samuel A., Hasbun, Rodrigo
openaire +2 more sources
Assessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. [PDF]
Using a capture-recapture method, this study evaluates the completeness of the cutaneous leishmaniasis (CL) surveillance system in four districts of Santiago del Estero province, Argentina, for the period 1990-1993. Four reporting sources were evaluated:
Yadón, ZE +16 more
core +1 more source
Assessment of the effects of bean extract on axillary hair reduction [PDF]
Objective: Body hair removal plays an important role in beauty standards, particularly for women. Finding a method that is easy to use, cheap, and can be done without supervision can significantly affect long-term hair reduction and reduce the side ...
Fereshteh Zamiri +6 more
doaj +1 more source
Cutaneous Leishmaniasis in Turkey
Cutaneous leishmaniasis (CL) caused by Leishmania protozoon parasites is a disease which is characterized by long-term nodulo-ulcerative lesions healing spontaneously with scarring. The disease has been well-known in Anatolia for centuries and has different names such as; Urfa boil, Antep boil, year boil, Halep boil, oriental sore and beauty scar.
Mehmet Salih, Gürel +3 more
openaire +2 more sources
Background Lupoid cutaneous leishmaniasis (LCL) is known as a rare but serious complication of anthroponotic cutaneous leishmaniasis (ACL) resistant to conventional treatments.
Sara Molkara +7 more
doaj +1 more source

